Literature DB >> 33099481

Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.

Nara Yoon1, Hyun-Soo Kim2, Jung Whee Lee3, Eui-Jin Lee4, Lee-So Maeng5, Wan Soo Yoon6.   

Abstract

BACKGROUND/AIM: Glioblastoma is the most malignant form of astrocytoma. The purpose of this study was to analyze the genetic characteristics of primary and recurrent glioblastomas using targeted sequencing and investigate the differences in mutational profiles between the locations of tumor recurrence.
MATERIALS AND METHODS: Fourteen glioblastoma patients who developed local (n=10) or distal (n=4) recurrence were included in the study. Targeted sequencing analysis was performed using the primary (n=14) and corresponding recurrent (n=14) tumor tissue samples.
RESULTS: The local and distal recurrence groups showed different genetic evolutionary patterns. Most of the locally recurrent glioblastomas demonstrated concordant mutational profiles between the primary and recurrent tumors, suggesting a linear evolution. In contrast, all cases of distally recurrent glioblastomas showed changes in mutational profiles with newly acquired mutations when compared to the corresponding primary tumors, suggesting a branching evolution.
CONCLUSION: Locally and distally recurrent glioblastomas exhibit different evolutionary patterns. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Brain; evolutionary pattern; glioblastoma; recurrence; targeted sequencing

Mesh:

Substances:

Year:  2020        PMID: 33099481      PMCID: PMC7675659          DOI: 10.21873/cgp.20234

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  52 in total

1.  Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.

Authors:  Beth K Neilsen; Richard Sleightholm; Rodney McComb; Shakti H Ramkissoon; Jeffrey S Ross; Robert J Corona; Vincent A Miller; Matthew Cooke; Michele R Aizenberg
Journal:  J Neurooncol       Date:  2018-12-09       Impact factor: 4.130

2.  Glioblastoma Factors Increase the Migration of Human Brain Endothelial Cells In Vitro by Increasing MMP-9/CXCR4 Levels.

Authors:  Luciane Vieira DE Oliveira Rosario; Barbara Gomes DA Rosa; Thaynan Lopes Goncalves; Diana Isabel Lourenco Matias; Catarina Freitas; Valeria Pereira Ferrer
Journal:  Anticancer Res       Date:  2020-05       Impact factor: 2.480

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Adaptive Radiotherapy for Glioblastoma Multiforme - The Impact on Disease Outcome.

Authors:  ZoltÁn VÉgvÁry; Barbara DarÁzs; Viktor Paczona; Ágnes Dobi; Zita Reisz; ZoltÁn Varga; Emese Fodor; Adrienn CserhÁti; Judit OlÁh; DÁvid Kis; PÁl BarzÓ; Katalin HideghÉty
Journal:  Anticancer Res       Date:  2020-08       Impact factor: 2.480

Review 5.  Molecularly targeted therapies for recurrent glioblastoma: current and future targets.

Authors:  Darryl Lau; Stephen T Magill; Manish K Aghi
Journal:  Neurosurg Focus       Date:  2014-12       Impact factor: 4.047

6.  Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.

Authors:  C B Scott; C Scarantino; R Urtasun; B Movsas; C U Jones; J R Simpson; A J Fischbach; W J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

7.  Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration.

Authors:  Francesco Pasqualetti; Alessandra Gonnelli; Alessandro Molinari; Martina Cantarella; Sabrina Montrone; Agostino Cristaudo; Davide Baldaccini; Roberto Mattioni; Durim Delishaj; Valentina Mazzotti; Riccardo Morganti; Paola Cocuzza; Maria Grazia Fabrini; Giuseppe Lombardi; Roberta Rudà; Riccardo Soffietti; Fabiola Paiar
Journal:  Anticancer Res       Date:  2018-10       Impact factor: 2.480

Review 8.  Epidermal growth factor receptor dependence in human tumors: more than just expression?

Authors:  Carlos L Arteaga
Journal:  Oncologist       Date:  2002

9.  Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.

Authors:  Francesca Orzan; Francesca De Bacco; Giovanni Crisafulli; Serena Pellegatta; Benedetta Mussolin; Giulia Siravegna; Antonio D'Ambrosio; Paolo M Comoglio; Gaetano Finocchiaro; Carla Boccaccio
Journal:  Stem Cells       Date:  2017-09-29       Impact factor: 6.277

10.  Role of B-Cell Translocation Gene 1 in the Pathogenesis of Endometriosis.

Authors:  Jeong Sook Kim; Young Sik Choi; Ji Hyun Park; Jisun Yun; Soohyun Kim; Jae Hoon Lee; Bo Hyon Yun; Joo Hyun Park; Seok Kyo Seo; SiHyun Cho; Hyun-Soo Kim; Byung Seok Lee
Journal:  Int J Mol Sci       Date:  2019-07-09       Impact factor: 5.923

View more
  3 in total

1.  Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma.

Authors:  Hyunjin Kim; Go Eun Bae; Yoon Yang Jung; Hyun-Soo Kim
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

2.  Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression.

Authors:  Sangjoon Choi; So-Woon Kim; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

3.  A Targeted Next-Generation Sequencing Panel to Genotype Gliomas.

Authors:  Maria Guarnaccia; Laura Guarnaccia; Valentina La Cognata; Stefania Elena Navone; Rolando Campanella; Antonella Ampollini; Marco Locatelli; Monica Miozzo; Giovanni Marfia; Sebastiano Cavallaro
Journal:  Life (Basel)       Date:  2022-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.